| Epidemiology of acute renal failure: a prospective, multicenter, community-based study F Liaño, J Pascual KIDNEY INTERNATIONAL 50, 811-818, 1996 | 1457 | 1996 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 511 | 2019 |
| KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation SJ Chadban, C Ahn, DA Axelrod, BJ Foster, BL Kasiske, V Kher, D Kumar, ... Transplantation 104 (4S1), S11-S103, 2020 | 442 | 2020 |
| European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care D Abramowicz, P Cochat, FHJ Claas, U Heemann, J Pascual, C Dudley, ... Nephrology Dialysis Transplantation 30 (11), 1790-1797, 2015 | 360 | 2015 |
| Characterization of ACE and ACE2 expression within different organs of the NOD mouse H Roca-Ho, M Riera, V Palau, J Pascual, MJ Soler International journal of molecular sciences 18 (3), 563, 2017 | 343 | 2017 |
| Prognosis of acute tubular necrosis: an extended prospectively contrasted study F Liaño, A Gallego, J Pascual, F García-Martín, JL Teruel, R Marcén, ... Nephron 63 (1), 21-31, 1993 | 334 | 1993 |
| Everolimus with reduced calcineurin inhibitor exposure in renal transplantation J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ... Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018 | 256 | 2018 |
| Atherosclerosis in chronic kidney disease: more, less, or just different? JM Valdivielso, D Rodríguez-Puyol, J Pascual, C Barrios, ... Arteriosclerosis, thrombosis, and vascular biology 39 (10), 1938-1966, 2019 | 242 | 2019 |
| Steroid avoidance or withdrawal for kidney transplant recipients MC Haller, A Royuela, EV Nagler, J Pascual, AC Webster Cochrane Database of Systematic Reviews, 2016 | 198 | 2016 |
| Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period MWM Van De Luijtgaarden, KJ Jager, M Segelmark, J Pascual, F Collart, ... Nephrology Dialysis Transplantation 31 (1), 120-128, 2016 | 181 | 2016 |
| Cardiovascular and noncardiovascular mortality among men and women starting dialysis JJ Carrero, DJ de Jager, M Verduijn, P Ravani, J De Meester, JG Heaf, ... Clinical Journal of the American Society of Nephrology 6 (7), 1722-1730, 2011 | 177 | 2011 |
| Gut-microbiota-metabolite axis in early renal function decline C Barrios, M Beaumont, T Pallister, J Villar, JK Goodrich, A Clark, ... PloS one 10 (8), e0134311, 2015 | 166 | 2015 |
| Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial F Moreso, M Crespo, JC Ruiz, A Torres, A Gutierrez-Dalmau, A Osuna, ... American Journal of Transplantation 18 (4), 927-935, 2018 | 164 | 2018 |
| The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry M Pippias, KJ Jager, A Kramer, T Leivestad, MB Sánchez, FJ Caskey, ... Nephrology Dialysis Transplantation 31 (5), 831-841, 2016 | 164 | 2016 |
| Everolimus plus early tacrolimus minimization: a phase III, randomized, open‐label, multicentre trial in renal transplantation RM Langer, R Hene, S Vitko, M Christiaans, H Tedesco‐Silva Jr, ... Transplant International 25 (5), 592-602, 2012 | 149 | 2012 |
| A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation J Pascual, C Galeano, A Royuela, J Zamora Transplantation 90 (4), 343-349, 2010 | 149 | 2010 |
| Causes and prognosis of acute renal failure in the very old J Pascual, F Liaño, Madrid Acute Renal Failure Study Group Journal of the American Geriatrics Society 46 (6), 721-725, 1998 | 144 | 1998 |
| Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review J Pascual, A Royuela, C Galeano, M Crespo, J Zamora Nephrology Dialysis Transplantation 27 (2), 825-832, 2012 | 143 | 2012 |
| Novel views on new-onset diabetes after transplantation: development, prevention and treatment M Hecking, J Werzowa, M Haidinger, WH Hörl, J Pascual, K Budde, ... Nephrology Dialysis Transplantation 28 (3), 550-566, 2013 | 142 | 2013 |
| 12‐month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients H Tedesco‐Silva Jr, S Vitko, J Pascual, J Eris, JC Magee, J Whelchel, ... Transplant International 20 (1), 27-36, 2007 | 134 | 2007 |
